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Being crucial under several pathological conditions, tumors, and tissue engineering, the MRI tracing of
hypoxia within cells and tissues would be improved by the use of nanosystems allowing for direct reco-
gnition of low oxygenation and further treatment-oriented development. In the present study, we functio-
nalized dendron-coated iron oxide nanoparticles (dendronized IONPs) with a bioreductive compound, a
metronidazole-based ligand, to speciﬁcally detect the hypoxic tissues. Spherical IONPs with an average
size of 10 nm were obtained and then decorated with the new metronidazole-conjugated dendron. The
resulting nanoparticles (metro-NPs) displayed negligible eﬀects on cell viability, proliferation, and metab-
olism, in both monolayer and 3D cell culture models, and a good colloidal stability in bio-mimicking
media, as shown by DLS. Overtime quantitative monitoring of the IONP cell content revealed an
enhanced intracellular retention of metro-NPs under anoxic conditions, conﬁrmed by the in vitro MRI of
cell pellets where a stronger negative contrast generation was observed in hypoxic primary stem cells and
tumor cells after labeling with metro-NPs. Overall, these results suggest desirable properties in terms of
interactions with the biological environment and capability of selective accumulation into the hypoxic
tissue, and indicate that metro-NPs have considerable potential for the development of new nano-plat-
forms especially in the ﬁeld of anoxia-related diseases and tissue engineered models.
1. Introduction
Nanotechnology developments have produced innovative tools
that have had a tremendous impact on the field of biomedi-
cine, attracting growing scientific interest especially for
disease diagnosis and development of nano-based therapeutic
strategies.1–3 So far, a number of engineered nano-objects have
been proposed for multifunctional purposes such as imaging
platforms, biosensors, and photothermal, antimicrobial or
chemotherapeutic agents.4,5 Nanoparticles endowed with mag-
netic properties (MNPs) owe their success to their unique pro-
perties of biocompatibility, stability, and magnetic behavior,
which make them perfect for interacting with biological
systems with the possibility of remote control.6,7 Iron oxide
nanoparticles (IONPs) represent the most outstanding class of
MNPs, exhibiting a crystalline structure based on Fe3O4 (mag-
netite) or γ-Fe2O3 (maghemite) and characterized by diﬀerent
scales and various tridimensional geometries.8 On reducing
their size, the IONPs acquire superparamagnetic properties
that enhance their performance as contrast agents in magnetic
resonance imaging (MRI), therapeutic agents for hyperther-
mia, drug delivery platforms, and tools for cell separation and
detection.9,10 In order to maximize the stability and solubility
of nanoformulations in the biological milieu and their com-
patibility in a physiological environment, various types of
molecular coatings have been developed. Even though thus
far, the most common choices have been polymers, such as
dextran, chitosan, polyethylene glycol (PEG) or polyvinyl pyrro-
lidone (PVP),11 and the need for systematic approaches to sim-
plify the synthesis of the molecular coating components and
to optimize the specific physico-chemical characteristics of the
outer shell (e.g. mechanical resistance, thickness, chemical
groups exposed on the outer surface) has driven the search for
new synthetic coating molecules. In this regard, dendrimers
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c9nr08436c
aDepartment of Biomedical Engineering, University of Basel, Gewerbestrasse 14,
4123, Allschwil, Basel, Switzerland. E-mail: arnaud.scherberich@usb.ch
bDepartment of Biomedicine, University Hospital Basel, University of Basel,
Hebelstrasse 20, 4031 Basel, Switzerland
cUniversité de Strasbourg, CNRS, Institut de Physique et Chimie des Matériaux de
Strasbourg, UMR 7504, F-67000 Strasbourg, France
dMolecular and Preclinical Imaging Centers, Department of Molecular Biotechnology
and Health Sciences, University of Torino, Torino, Italy





























































































e. View Article Online
View Journal  | View Issue
have attracted special interest due to the tunability of their pro-
perties and their modular synthetic generation.12 Particularly,
the direct grafting of small-sized and well defined dendrons
on the surface of nanoparticles has proved to be a successful
strategy for designing functional IONPs.13 The dendrons can
be strongly anchored to the IONP surface via biphosphonate
tweezers, resulting in nanosuspensions with good colloidal
stability in water and isoosmolar media.14 Eﬃcient dendrons
based on oligoethyleneglycol units, one hexa or octaethyl-
eneglycol chain ending with a carboxylate function,
optionally adjoining two tetraethyleneglycol chains have
already been synthesized in both linear and dendrimeric
forms.15
Several kinds of IONPs have been conjugated with drugs,
proteins, enzymes, antibodies, or nucleotides for delivery to
target organs, tissues, or tumors. One of the most convention-
al applications is the hyperthermic treatment and molecular
imaging of cancer cells.16 Limited vascularization in solid
tumors allows cancer cells to grow and survive, thus outcom-
peting normal cells in the microenvironment.17 Decreased
tissue oxygen tension is a component also found in many
other intractable diseases, as well as an obstacle in several
therapeutic approaches. For instance, the cell viability inside
tridimensional tissue-like constructs for regenerative medicine
is strongly dependent on the oxygenation level, since the
diﬀusion of oxygen and nutrients to cells from capillary net-
works does not exceed 100–200 μm.18 Because the low pressure
of oxygen represents a marked feature of pathological tissues,
the conjugation of bioreductive compounds to molecular
probes has been extensively exploited to detect and reach
hypoxic cells.19 Bioreductive molecules are selectively reduced
in hypoxic tissues, generating reactive intermediates that bind
to intracellular molecules. For instance, nitroimidazole and its
derivatives successfully deliver systems to poorly-perfused
hypoxic regions in solid tumors.19,20 The 5-nitroimidazole,
metronidazole, becomes reductively activated by the pyruvate :
ferredoxin oxidereductase system under anoxic conditions.21
The anaerobic environment triggers metronidazole’s capability
to bind DNA and other intracellular macromolecules, enabling
the stable accumulation of the drug inside the cells.22–24 This
property can be exploited to either selectively image hypoxic
cells or to kill target cells (for instance for antimicrobial
purposes).25,26 Metronidazole has become a common starting
material for the preparation of radiopharmaceuticals that
eﬃciently recognize hypoxic tumors in vitro and in vivo, thanks
to the ease of conjugation that preserves the specific sites of
recognition and the biological activity of the ligand.20
However, the use of non-radioactive IONPs as contrast agents
would be preferable to avoid the limitations associated with
radioactive tracers and to provide a nanosized platform for
further treatment-oriented development (e.g., as drug carriers,
or hyperthermic agents). Hence, a system combining bioreduc-
tive compounds and IONPs would allow achieving an active
recognition of the hypoxic gradients and their visualization in
high space resolution by safe and versatile imaging based on
the magnetic resonance.
In the present paper, a novel dendron functionalized with
one unit of metronidazole (metro-dendron) was used to dec-
orate the surface of spherical IONPs and create novel hypoxia-
activated nanoparticles (metro-NPs). To make the NPs also
optically traceable, the molecule was also further labeled with
a fluorophore (Alexafluor647), as previously reported.14 Here,
we provide a preliminary in vitro characterization of the novel
nanoparticles, investigate their interaction with the biological
environment in terms of cytotoxicity, cell internalization and
stability in fluids mimicking physiological conditions, and
assess their capability of intracellular accumulation into the
hypoxic environment.
2. Materials and methods
Synthesis of metronidazole-functionalized dendrons
The synthesis of dendrons was based on a previously reported
protocol.27 All the steps of the synthetic procedure are
described in the ESI (Schemes S1–S4†), and the resulting pro-
ducts were characterized by 1H and 31P NMR spectroscopy
(Fig. S2–S8†) with a NMR instrument equipped with 1H
(500 MHz), 13C (125 MHz) and 31P (121 MHz) probes (Bruker,
Billerica, Massachusetts, USA). A benzyloxy-protected bispho-
sphonate (reported as intermediate 4 in Scheme S1†) was the
key platform for diversification by functionalizing the phenolic
group with a metronidazole moiety. The final deprotection of
phosphonate groups was secured by heating to reflux a solu-
tion of metronidazole-bisphosphonate (namely, dendron 5 in
Scheme S1†) in dichloromethane with trimethylsilylbromide.
Synthesis and functionalization of nanoparticles
In a 100 mL two-necked flask, iron(II) stearate (2.2 mmol,
1.38 g), oleic acid (4.4 mmol, 1.24 g) and dioctylether (20 mL)
were mixed together. The resulting solution was heated up to
120 °C and kept for 1 h under magnetic stirring without a
reflux condenser. Then, the magnetic stirrer was removed and
the condenser was connected to the flask. The solution was
heated up to 298 °C for 2 h with a heating rate of 5 °C min−1.
After cooling down, a black suspension was precipitated by the
addition of acetone and collected. Finally, the NPs were
washed three times with a 1 : 4 mixture of chloroform :
acetone. To functionalize the NP surface, a nanoparticle sus-
pension in THF (5 mg of iron) was mixed with compound 6
(Scheme S1,† 5.25 mg) in a 30 mL vial, which was further com-
pleted with 25 mL of THF. The mixture was magnetically
stirred for 30 min, and then compound 7 (1.75 mg) was added
to the reaction mixture, and stirred for 24 h. The resulting par-
ticles were centrifuged by the addition of cyclohexane, dis-
persed in water and washed by ultrafiltration through cellulose
membranes with a nominal molecular weight limit (NMWL) of
3 kDa. Briefly, after introducing 25 ml of the water suspension
in the apparatus, the purification occurred by pressurizing the
solution flow: whereas solvent and ungrafted molecules went
through the membrane, the grafted NPs did not pass through
and were redispersed in 25 ml of water and then subjected to
Paper Nanoscale































































































another ultrafiltration step. This was done five times.13 The
metro-NPs were obtained by coating the bare IONPs with
metro-dendrons 6 and unfunctionalized dendrons 7 at a ratio
of 3 : 1. This ratio was obtained by stoichiometrically adding
metro-dendrons and unfunctionalized dendrons to the iron
oxide suspension, before characterizing through infrared spec-
troscopy (Fig. S11†). Being the molecular area of a dendron
governed by the surface area of the three-branched oligoethyl-
ene glycol (OEG) chains, it was possible to estimate by theore-
tical calculation that the number of dendrons grafted at the
10 nm-sized IONP surface could be around 600.28 NPs deco-
rated at 100% by the unfunctionalized dendrons were used as
controls.28 To make the NPs also optically traceable, the den-
drons were also further labeled with a fluorophore
(Alexafluor647), as previously reported.14
TEM
For the morphological studies, transmission electron
microscopy (TEM) images of the IONPs in the organic medium
were recorded with a JEOL 2100 TEM instrument (JEOL,
Tokyo, Japan), operating at 200 kV, with a point-to-point
resolution of 0.5 nm.
Dynamic light scattering
Dynamic light scattering (DLS, Zetasizer Nano 90 ZS, Malvern,
UK) allowed for the determination of the mean hydrodynamic
diameter of vesicles and their polydispersity index (PDI). In
order to calculate the particle size, a scattering angle of 90
degrees was used. All measurements were performed in tripli-
cate at 25 °C. Zeta potential measurements were initiated
immediately after purification by ultrafiltration of the samples
and carried out in triple samples, measured three times each
at 21 °C and pH 5.3.
Cell lines
All cell lines were obtained from the American Type Culture
Collection (ATCC, Manassas, VA, USA) and were tested for
mycoplasma (MycoAlertTM Mycoplasma Detection Kit, Lonza
AG, Basel, Switzerland). Murine macrophages (RAW 264.7 cell
line) were cultured in monolayer at 37 °C in a 5% CO2-contain-
ing humidified atmosphere in Dulbecco’s modified Eagle’s
medium (DMEM). The medium was supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (FBS), 2 mM gluta-
mine, 100 U mL−1 penicillin, and 100 μg mL−1 streptomycin
(all from ThermoFischer Scientific, Switzerland). Human
umbilical vein endothelial cells (HUVEC) were cultured in
M199 medium supplemented with 20% FBS, 100 mg mL−1
endothelial cell growth supplement, 50 IU mL−1 heparin,
100 IU mL−1 penicillin, and 100 mg mL−1 streptomycin.
Cell viability tests
In the perspective of their potential use for biomedical appli-
cations, the biocompatibility of the dendronized nanoparticles
underwent a series of cytotoxicity tests in order to evaluate
their compatibility with living systems. HUVEC cells were incu-
bated with the nanoparticles in the culture medium at
diﬀerent concentrations (ranging from 5 to 150 µg mL−1) and
for various time ranges (from 1 h to 2 days) at 37 °C. Then, the
cell viability was estimated via the trypan blue exclusion assay.
The reported viability percentages represent the average ratios
between the number of viable cells, Nv, and the total number
of cells, Ntot (Nv/Ntot × 100). Moreover, cytotoxicity results were
further studied by assessing the release of the cytoplasmic
enzyme, lactate dehydrogenase (LDH), into the media from
damaged or dead cells with leaky membranes.29,30 For the
LDH cytotoxicity assay, the cells were seeded in 24 well-plates
at a concentration of 2.0 × 104 cells per well. After 12 h, a
100 μL aliquot of the media was collected and the released
LDH was quantified by mixing with an NADH-buﬀered solu-
tion and pyruvate solution. The LDH activity was measured
spectrophotometrically by following the conversion of NADH
to NAD+, at 340 nm.29 The results are expressed as a percen-
tage of the respective controls, representing the basal LDH
released by cells incubated with the culture medium in the
absence of NPs. Additionally, cell viability was assessed by the
mitochondria-dependent reduction of MTT to formazan. After
labeling, 2.0 × 104 cells per well were seeded in 48-well plates.
After 24 h, the cells were incubated with 1 mL per well of MTT
(0.5 mg mL−1) at 37 °C. Approximately 4 to 6 h were required
to produce formazan; supernatants were discarded and forma-
zan was then dissolved in DMSO. The solutions were trans-
ferred to a 96-well plate and the extent of MTT reduction to for-
mazan within the cells was quantified by the measurement of
the optical density at 550 nm. The results are expressed as a
percentage of the respective control (incubation in medium in
the absence of NPs). Duplicate measurements were performed
in three independent experiments.
Proliferation rate assessment
The proliferation rates of endothelial cells (HUVEC) and
macrophages (RAW 264.7) after a 3 h incubation with nano-
particles at two diﬀerent dosages (25 and 75 µg mL−1) were
monitored over 8 days. Briefly, 2.5 × 104 cells per well were
seeded in 24-well plates and their proliferation rate was
assessed with the CyQuant direct cell proliferation assay
according to the manufacturer’s protocol. The optical density
(OD) was measured at 535 nm (530 to 560 nm excitation) in
order to determine the amount of DNA in the wells 6 and 12 h
and 1, 2, 4, and 8 days after incubation. The corresponding
cell numbers were found by using calibration curves obtained
from the same batch of cells and plotted against the culture
time to obtain the proliferation rate curves.
3D regenerative models with NP-labeled cells
Stromal vascular fraction (SVF) cells were isolated from
adipose tissues.31,32 Briefly, liposuctions were obtained from
15 healthy donors after informed consent and according to a
protocol approved by the Ethical Committee of the Canton of
Basel (Ethikkommission beider Basel [EKKB], Ref. 78/07). The
isolation of SVF cells was carried out by enzymatic digestion at
37 °C for 45 min with 0.075% collagenase type II (Worthington
Biochemical Corp., Lakewood, NJ) and centrifugation
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(1700 rpm, 10 min), as previously described.33 Finally, a com-
plete medium (CM) consisting of α-MEM supplemented with
10% fetal bovine serum (FBS), 1% HEPES, 1% sodium pyru-
vate, 1% penicillin (10 000 U mL−1), streptomycin (10 000 µg
mL−1) and L-glutamine (29.2 mg mL−1) solution (PSG solution,
ThermoFisher Scientific, Switzerland) was used to suspend the
cells before they were filtered through a 100 µm strainer
(Sarstedt, Numbrecht, Germany) and counted. For NP labeling,
the cells were incubated with a medium containing 25 µg
mL−1 NPs for 3 h at 37 °C, washed with PBS three times, and
directly used to generate the constructs. The 3D constructs
were obtained from the co-assembly of SVF cells, fibrin, and
fragments of decellularized matrix of adipose-derived scaﬀold-
ing materials, as previously reported.33 The final constructs
(final volume of 40 µL) were maintained under standard
culture conditions for 3 days before testing the proliferation
rate and metabolic activity of seeded cells over time.
Proliferation and metabolic activity in 3D constructs
DNA quantification was performed with a commercially avail-
able fluorescence based kit (Quant-iTTM PicoGreen® dsDNA
kit, #P7589, Invitrogen) according to the manufacturer’s
instructions following the mechanical disruption of constructs
by pipetting and resuspension of the material into double dis-
tilled water. Fluorescence was measured with a Spectra Max
Gemini XS microplate spectrofluorometer (Molecular Devices)
with excitation and emission wavelengths of 485 nm and
538 nm, respectively. The alamarBlue assay was performed to
determine the metabolic activity of seeded cells. The culture
medium was supplemented with 10% (v/v) of alamarBlue
reagent solution at 0.1 mg mL−1 (#R7017, Sigma-Aldrich) and
incubation was carried out for 4 h at 37 °C before the fluo-
rescence signal (at 570 and 600 nm) was measured with a
Synergy H1 microplate reader (Biotek). Fluorescence intensity
values were normalized to internal controls. The metabolic
activity per cell was normalized to both the cell number and
fluorescence intensity values of the first experimental time
point (day 0).
Internalization and retention of nanoparticles by the cells
In order to assess the internalization rate of nanomaterials,
the cells (HUVEC and Raw264.7, 1.0 × 106) were incubated
with medium containing NPs (25 µg mL−1, 37 °C) for various
time ranges. Then the cells were washed with PBS three times,
centrifuged, and re-suspended in 10% SDS. After 1 min of vor-
texing, the homogenates were heated at 70 °C, and the amount
of NPs inside the cell suspensions was estimated by iron
quantification based on spectrophotometric absorbance
according to the following formula:
Feðμg mL1Þ ¼ ðA370 nm  ðB A750 nmÞÞ=S370 nm
where the ratio A370 nm/A750 nm represents lysed unlabeled
control cells and S370 nm represents the slope of the Fe stan-
dard curve. B is the correction factor for turbidity to convert
absorbance from the cellular absorbance at 750 nm to its
370 nm equivalent so that through subtraction, only the iron
is measured. Since the nanoparticles were decorated with the
fluorophore Alexafluor647, the internalization was also
assessed by counting the number of cells positive for fluo-
rescence at 647 nm. The ratio between the positive cells and
number of nuclei (DAPI positive) represented the positive frac-
tion on the observed population. After incubation (37 °C, 3 h,
25 µg mL−1), the retention of NPs inside HUVEC cells was
assessed over time and quantified by fluorescence intensity.
The optical density (emission at 650 nm) of NP-labeled cells
was measured. Finally, the release of nanoparticles from 3D
constructs containing SVF cells pre-labeled with NPs (37 °C,
3 h, 25 µg mL−1) was also assessed by quantification of iron in
the culture medium by measuring the absorbance at 370 nm.
The inhibition of clathrin-mediated endocytosis was tested by
co-incubation with 100 µM chlorpromazine (CPZ) hydro-
chloride (C8138, Sigma-Aldrich, Switzerland).
Stability in biological media
The stability of NPs in biological media was investigated by
incubating them in cell culture medium (DMEM), with
Human Serum Albumin (HSA) solution (0.65 mM, pH 7.4) or
reconstituted Human Serum (HS) (50 mg mL−1, pH 7.4) to
simulate the plasmatic environment. Incubations with PBS
and HEPES were used as controls. Appropriate amounts of
HSA (Sigma-Aldrich, St Louis, USA) and freeze-dried aliquots
of HS proteins (SERO, Billingstad, Norway) were reconstituted
to obtain a final protein concentration in the incubation
sample, mimicking physiological conditions. Incubation tubes
were maintained at 37 °C. In order to test the occurrence and
the possible eﬀects of the interaction between proteins and
NPs, the level of NP aggregation was studied through DLS, in
terms of size and polydispersity changes. Since DLS measure-
ments can be severely aﬀected by the presence of proteins, the
samples were previously dialyzed using membranes with a
100 kDa molecular weight cut-oﬀ, which permit the transit of
proteins, but prevent the passage of the much bigger NPs.
Hemolysis assay
The haemocompatibility of metro-NPs was evaluated according
to the in vitro red blood cell (RBC) hemolysis test. The white
cells were first removed from human blood samples, obtained
from Blutspendezentrum, at the University Hospital of Basel.
Finally, erythrocytes were dissolved in PBS at 2% concentration
and mixed with an equal volume of physiological saline, NPs,
and metro-NPs of 0.5 mg ml−1, respectively. A positive hemoly-
sis control was prepared by adding an equal volume of erythro-
cyte suspension and distilled water. After the mixture was
maintained for 1 and 3 h at 37 °C and then centrifuged at
2000 rpm for 5 min, the supernatants were detected with a
microplate reader (Bio-Rad, Hercules, CA) at 570 nm. The per-
centage of hemolysis was calculated by the equation: hemoly-
sis (%) = (ODt − ODnc)/(ODpc − ODnc) × 100, where ODT, ODNC,
and ODPC refer to the absorbance values of the sample, nega-
tive control, and positive control, respectively.
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The constructs were fixed overnight in a 4% paraformaldehyde
solution. If necessary, the samples were decalcified in a 7%
EDTA solution, before being embedded into paraﬃn.
Histological sections (4.5 µm thickness) were stained with
hematoxylin and eosin (#GHS116 and #HT110116, respectively,
from Sigma Aldrich).
Hypoxia induction
Hypoxic cells were obtained either by a long incubation under
hypoxic conditions (1% O2) or by chemical induction.
Specifically, in the latter case, the cellular hypoxia was trig-
gered by adding the chemical inducer of hypoxia-inducible
factor, cobalt(II) chloride hexahydrate (CoCl2·6H2O),
34 to the
culture medium. A 25 mM stock solution of CoCl2 in bidis-
tilled water was prepared immediately before use and added to
the cell culture medium for a final concentration of 100 μM.35
The cultures were incubated for 24 h in a conventional incuba-
tor (37 °C, 5% CO2). Also the hypoxic tissue constructs and
pellets for MRI were obtained through CoCl2-chemical
induction.
Prussian blue staining of cells
After IONP internalization, the cells were washed twice with
PBS and fixed with 4% paraformaldehyde solution for 30 min
at room temperature. After washing again twice with PBS, the
cells were incubated with the Prussian blue staining solution,
namely a 1 : 1 mixture of 4% potassium ferrocyanide (Sigma-
Aldrich) and 4% hydrochloric acid (Sigma-Aldrich) for 15 min
at room temperature and finally, washed with distilled water
three times. The counterstaining was done for cytoplasm with
eosin (Panreac Química S.L.U) for 5 min at room temperature.
After washing, the cells were observed using inverted light
microscopy (Olympus IX83, Life Science, Germany). All experi-
ments were carried out in triplicate.
In vitro magnetic resonance imaging of cell phantoms
The cells were seeded at a density of 2.0 × 106 in a 75 cm2
tissue culture flask, labeled with nanoparticles as described
before, washed with PBS three times and kept in culture under
either hypoxic or normoxic conditions for 3 days. After detach-
ment, the cells were fixed with 4% formalin for 30 min,
washed twice with PBS, and counted. 1.0 × 106 cells were col-
lected by centrifugation, suspended in 50 μl PBS and trans-
ferred to glass capillaries. The capillaries were centrifuged
(5 minutes, 1500 rpm), and loaded onto a support for in vitro
MRI containing an agar-based matrix to avoid susceptibility
artifacts due to air. The capillaries were imaged on their axial
section in a Bruker Avance 300 spectrometer (Billerica,
Massachusetts, USA) equipped with a micro-imaging probe
working at 7.1 T. T1 w-images were acquired using a standard
T1 w-MSME (MultiSlice MultiEcho). The first set of images was
acquired with a sequence set with the following parameters:
Time of Repetition (TR) = 200 ms, Time of Echo (TE) =
3.74 ms, Field of View (FOV) = 1.2 × 1.2 cm2, matrix size =
128 × 128 pu (pixel units), slice thickness = 1.0 mm, number
of slices = 3, and average number = 16, for a final acquisition
time (TA) of 6 min 49 s. A standard saturation recovery protocol
was used to measure T1 relaxation times: variable TR = 50, 100,
200, 400, 600, 1000, 1500, 3000, 5000, and 8000 ms, for a final
acquisition time of 42 min 39 s. The T2 w-images were acquired
using a T2 w-RARE (Rapid Acquisition with Refocused Echoes)
sequence with (TR) = 4000 ms, FOV = 1.20 × 1.20 cm2, slice
thickness = 1 mm, number of slices = 3, average number = 8,
RARE factor = 32, TE = 3.9 ms, eﬀective TE = 58.70 ms, and
matrix = 128 × 128 pu, for a final acquisition time (TA) of
2 min 8 s. A MSME protocol was used to measure T2 relaxation
times: variable TE = 14, 28, 42, 56, 70, 84, 98, 112, 126, 140,
154, 168, 182, 196, 210, 224, 238, 252, 266, and 280 ms, for a
final acquisition time of 8 min 32 s. The percentage T1 and T2
Contrast Variation (T2-CV) was calculated on the T1 weighted and
T2 weighted-images. The mean Signal Intensity (SI0) was calcu-
lated on ROIs manually drawn on the cell pellets and then nor-
malized with respect to the signal produced by the unlabelled
cell pellets (SIn-unlabeled), in order to obtain the normalized
signal intensity of labeled cell pellets, SIn-label. The T2-CV was
calculated with respect to the normalized signal measured for
the cells incubated with neat PBS (SIn-ctrl), by applying the fol-
lowing expression: T1/2 − CV [%] = (SIn-label − SIn-unlabeled)/
SIn-unlabeled × 100. The percentage relaxivity variations (R1/R2 V)
were calculated by applying an equivalent formula with values
of relaxivity (R1 and R2) extracted from MRI relaxivity measure-
ments: R1/R2 V [%] = (Rn-label − Rn-unlabeled)/Rn-unlabeled × 100.
Statistics
Statistical analysis was performed with OriginPro 8.5
(OriginLab, Northampton, MA, USA). All variables are
expressed as mean ± SD. Data have been acquired from at least
four independent experiments, unless otherwise stated. To
assess statistically relevant diﬀerences between two experi-
mental groups, the t-test was used (P < 0.05 and P < 0.01 are
expressed as * and **, respectively). A general linear two-way
ANOVA test was used to verify the hypothesis whether there
were changes in various parameters over time among the




The coating of NPs was generated through dendrons syn-
thesized according to a previously reported procedure.27 In
this way, a benzyloxy-protected bisphosphonate (indicated as
intermediate 4 in Scheme S1†) was prepared to be used as the
initial platform for subsequent deprotection and functionali-
zation on the phenolic group with a metronidazole-derivatized
OEG chain, and for further preparation of the bisphosphonic
acid. These three final steps provided a good overall yield
(69%) without compromising the purity, finally producing the
metro-dendron, namely compound 6 shown in Fig. 1A.
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Characterization of nanoparticles and suspensions
The metro-NPs were obtained by coating the bare IONPs with
metro-dendrons 6 and unfunctionalized dendrons 7 at a ratio
of 3 : 1 (Fig. 1A). IONPs decorated by the unfunctionalized
dendron only were used as controls (NPs).28 The NP mor-
phology and size were observed by TEM and DLS. A suspen-
sion of homogeneously sized particulate was obtained
(Fig. 1B and S9–S11†), where the dendronized-coating
increased the mean hydrodynamic diameter of NPs from
their original size of 10 nm to around 20 nm (Fig. 1C and D).
Moreover, the zeta-potential measured for metro-NPs slightly
diﬀered from that found for the unfunctionalized counter-
parts, corresponding to −6.4 ± 0.6 mV and −11.1 ± 0.7 mV,
respectively.
Eﬀects of metro-NPs on the viability and proliferation of cells
grown in monolayer
For their prospective use in biomedical applications, the
impact of the dendronized nanoparticles on cell viability
was first assessed on human umbilical vein endothelial cells
(HUVEC) grown in monolayer and exposed to diﬀerent nano-
material concentrations for various time durations. The
nanoparticles displayed a high level of biocompatibility with
short incubation times and low NP dosages; the viability was
always above 80% (Fig. 2A, B and S12†), and even under the
harshest conditions, namely the combination of the longest
incubation time (two days) and the highest dosage (150 µg
Fe mL−1), the viability only dropped by 20%. The eﬀects
induced by the targeted nanoparticles (metro-NPs) did not
substantially diﬀer from those caused by the untargeted
controls (NPs). Moreover, neither of the two formulations
altered the proliferation ability of HUVECs and murine
macrophages (RAW 264.7 cell line): after 3 h of incubation
in the presence of intermediate NP dosages (25 and 75 µg Fe
mL−1), all cells showed growth trends comparable to the
control cells incubated with equivalent volumes of PBS
(Fig. 2C, D and S13†).
3D regenerative models with NP-labeled cells
In order to test the utility of NPs in biological applications, we
labelled the cells employed to generate 3D in vitro tissue con-
structs. The stromal vascular fraction (SVF), a potent primary
cell source easily isolated from adipose tissue, was used.31,33,36
The cells were labelled with NPs (3 h, 25 µg Fe ml−1) and co-
assembled with fibrin and the AT-derived matrix (Fig. 3A). The
constructs were kept in culture for 3 days before the prolifer-
ation rate and the metabolic ability of cells was tested via
alamarBlue assay over time (Fig. 3B and C). After 3 weeks of
culture, the SVF cells labeled with metro-NPs and NPs dis-
played similar metabolic and proliferation rates to the
unlabeled controls.
Fig. 1 Metro-functionalized dendronized nanoparticles. (A) Iron oxide nanoparticles (IONPs) were coated with a dendrimeric-based outer shell,
composed of metronidazole-functionalized dendrons and unfunctionalized dendrons at a ratio of 3 : 1. Schemes of the ﬁrst generation phospho-
nated dendrons grafted onto the IONP surface are provided (referred to as compounds 6 and 7). (B) Transmission electron microscopy (TEM) images
of dendronized nanoparticles in water suspension at increasing magniﬁcations. (C) Particle size distribution of IONPs determined by dynamic light
scattering (DLS). (D) DLS of IONPs before functionalization and of dendronized IONPs as water, saline buﬀer, and phosphate buﬀered saline (PBS)
suspensions.
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Internalization and retention of NPs
As assessed by the spectrophotometric quantification of iron
in the cell homogenates, the amount of nanoparticles interna-
lized by the endothelial cells and macrophages after incu-
bation at a fixed NP concentration (25 µg Fe mL−1) increased
with longer exposure times (Fig. 4A). After 6 h of incubation,
3.5/4.0 pg Fe per cell was measured, revealing a relatively fast
internalization trend as compared to other nanoformulations
and labeling procedures.37,38 The functionalization of NPs
with the metro-vector did not alter the internalization rate, as
the two nanoformulations were taken up at similar rates.
Similar conclusions were obtained by counting the fraction of
fluorescence-positive cells after labeling with NPs additionally
decorated with the fluorochrome Alexa647 (Fig. 4B and S14†).
After labeling, the HUVECs retained the nanoparticles for
around three days when grown in monolayer under standard
culture conditions (Fig. 4C), whereas almost all NPs (≈90% of
the initial iron amount) were found in the supernatants of 3D-
constructs seeded with SVF cells at this time point (Fig. 4D).
Furthermore, in order to determine the internalization mecha-
nism of IONPs, the intracellular distribution was followed by
histological observation after incubation in the presence or
absence of chlorpromazine (CPZ), an inhibitor of clathrin-
dependent endocytosis. Fig. 4E reproduces some representa-
tive images after Prussian blue staining experiments showing a
high labeling eﬃciency under these conditions, with the NPs
reaching almost 100% of the cells and distributed homoge-
neously in the intracellular space outside the nucleus.
Moreover, in the presence of CPZ, the staining predominately
marked the cell boundaries, possibly highlighting the adher-
ence of the IONPs to the cell surface. However, the internaliz-
ation was drastically reduced, thus suggesting that the uptake
under regular labeling conditions mostly occurs through an
endocytosis-dependent pathway.
Stability in biological media
The colloidal stability of NPs in biological media was investi-
gated by incubating them in culture medium supplemented
with human serum albumin (HSA) solution (0.65 mM) or
reconstituted human serum (50% in volume) under conditions
designed to simulate the plasmatic environment (0.65 mM,
37 °C, pH 7.4). The eﬀects of interaction with proteins and par-
Fig. 2 Eﬀects of retro-NPs on the viability and proliferation ability of cells grown in monolayer. Viability of HUVEC cells after incubation (37 °C) with
diﬀerent dosages of functionalized and unfunctionalized nanoparticles (metro-NPs and NPs), as tested by (A) trypan blue exclusion and (B) LDH
cytotoxicity assays. Proliferation rates of (C) HUVECs and (D) Raw264.7 cells after incubation (37 °C, 3 h) with metro-NPs and untargeted NPs (25 µg
Fe mL−1). Equivalent volumes of PBS in the culture medium were used as controls.
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ticle aggregation were monitored by DLS over time (Fig. 5). The
polydispersity index (PDI) of NPs and metro-NPs in PBS or
HEPES was always below 0.2, thus confirming prolonged stabi-
lity in the buﬀer solution. No apparent aggregation occurred
in the cell culture medium or in the HSA solution. In the pres-
ence of human plasma, the NP size was uniform during the
first 24 h, although a small portion of aggregates was found at
48 h for both the formulations. However, this scattered size
distribution only contained around 10% population with an
average size of thousands of nanometers, but without massive
precipitation. The metro-functionalization did not alter the
capability of dendronized coating to prevent the formation of
large aggregates under conditions mimicking a physiological
environment, thus predicting a good stability in in vitro cell
culture medium and in vivo blood circulation. Finally, as
shown in Fig. 5F, over 3 h incubation in human blood no sig-
nificant hemolysis of erythrocytes was induced by NPs and
metro-NPs as compared to the normal saline group.
IONP retention in hypoxic cells
The capability of IONPs to specifically detect the hypoxic cells
was assessed. Briefly, after culturing with a low tension of
oxygen or exposure to chemical hypoxia-inducer CoCl2, the
cells were labeled with IONPs and their iron content was
measured over time and compared to that of the cells grown
under aerobic conditions. The rationale of this experimental
procedure was based on the assumption that metronidazole
exposed on the surface of IONPs might react with intracellular
components in a reductive environment and then accumulate
at a higher rate (Fig. 6A). The amount of initially internalized
IONPs was comparable among all conditions, but 1 and 3 days
after labeling, a higher amount of iron was quantified in
hypoxic cells incubated with metro-NPs (Fig. 6B and C). A
three-fold increased iron content was measured in the hypoxic
cells incubated with metro-NPs (Fig. 6C) further confirmed by
measuring the fluorescent signal at 647 nm (Fig. 6D) and
histological inspection by Prussian blue staining (Fig. S15†).
Finally, under hypoxic conditions, a diﬀerent kinetics of iron
release was also observed in 3D tissue constructs containing
SVF cells pre-labeled with metro-NPs. In fact, in these con-
structs, the metro-NPs were retained for longer times as com-
pared to the untargeted NPs (Fig. S16†), which instead were
released with a trend comparable to that observed in con-
structs cultured under a normoxic atmosphere (Fig. 4D).
In vitro magnetic resonance imaging of cell pellets
Eﬀective hypoxia-induced NP retention was also assessed by
testing the MRI performance of the labeled cells in vitro
(Fig. 7A) on human primary stem cells (ASCs, Fig. 7B) and a
breast cancer cell line (MCF7, Fig. 7C). Three days after label-
ing with metro-NPs, the hypoxic pellets (Fig. 7B) of both ASCs
and MCF7 appeared as the darkest ones on T2-weighted
images (T2 w-images), producing a decrease in the percentage
T2 contrast variation (T2-CV) equivalent to ≈2.1 and 1.8 times
Fig. 3 Generation of 3D constructs and assessment of cell number and metabolism. (A) 3D constructs were obtained through the co-assembly of
NP-labeled cells, ﬁbrin, and adipose tissue-derived matrix (AT-derived matrix). The constructs were kept in culture for 3 days before the (B) viability
and (C) metabolism were assessed with the alamarBlue assay on the supernatants.
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Fig. 4 Internalization and retention of NPs by cells. (A) Amount of iron quantiﬁed in the cells and (B) percentages of ﬂuorescence-positive cells
after incubation with ﬂuorescently (Alexaﬂuor647) labeled nanoparticles (metro-NPs and control NPs, 25 µg Fe mL−1) for various time ranges.
Retention of NPs inside HUVECs over time after incubation (37 °C, 3 h, 25 µg Fe mL−1) as quantiﬁed by ﬂuorescence intensity. (C) The optical density
(emission at 650 nm) of the NP-labeled cells. (D) Release of nanoparticles from constructs containing SVF cells pre-labeled with NPs (37 °C, 3 h,
25 µg Fe mL−1), iron in the culture medium was quantiﬁed by measuring the absorbance at 370 nm. (E) Internalization and retention of NPs, shown
by Prussian blue staining of HUVEC cell cultures immediately after labeling under regular oxygen tension (top row). Equivalent volumes of PBS in the
culture medium were used as controls (unlabeled). The addition of the endocytosis-inhibitor, CPZ, drastically reduced the uptake of IONPs (bottom
row).
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the one induced by control NPs, respectively (Fig. S17†). Under
normoxic conditions, the two labeled cell pellets showed com-
parable T2-CV values resembling those of the NP-labeled
hypoxic cells, thus highlighting no specific activity of the tar-
geted system. Similar results were obtained in MCF7 cells
(MCF7, Fig. 7C), thus suggesting the opportunity of eﬃcient
hypoxic tumor imaging. Water relaxation rates in the cell
pellets were also measured in order to calculate the percentage
relaxivity variations (R1 and R2 V) induced by the nanosystems
under diﬀerent conditions, finding good accordance with the
Fig. 5 Colloidal stability in biological ﬂuids and hemolytic eﬀects. Mean hydrodynamic diameter (size, nm) and polydispersity index (PDI) of functio-
nalized and unfunctionalized nanoparticles (metro-NPs and control NPs) monitored by DLS over time, after incubation at 37 °C and pH 7.4 into
buﬀered solutions and ﬂuids mimicking the biological environment. Incubations were performed in (A) PBS, (B) HEPES buﬀer, (C) DMEM cell culture
medium, (D) HSA solution, and (E) and reconstituted HS. Hemolysis ratio in vitro after NPs and metro-NPs (0.5 Fe mg ml−1) treatment along diﬀerent
times (F).
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Fig. 6 Retention of IONPs in hypoxic cells. Scheme of the experimental procedure for the assessment of IONP retention after labeling of hypoxic
cells. (A) Hypoxic cells were obtained either by a long incubation under hypoxic conditions (1% O2) or by exposure to a chemical inducer of hypoxia-
inducible factor, CoCl2. IONP retention in the cell cultures after exposure to hypoxic conditions, obtained by incubation in (B and D) low O2 pressure
or (C and E) in the presence of CoCl2. The iron content of cell suspensions was assessed at several time points over 1 week after the initial labeling
by quantifying (B and C) cell iron content or (D and E) ﬂuorescence intensity at 647 nm. (F) Representative ﬂuorescence microscopy images of cell
cultures 3 days after exposure to CoCl2-induced hypoxic conditions (hypoxia) or control standard incubation (normoxia).
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contrast variation shown by the pictures (Fig. 7D and E). No
evident eﬀect was noticed on the modulation of longitudinal
relaxivity (R1) and the corresponding contrast variation
(Fig. 7D, E, and S18†). R2/R1 ratios for all pellets have also been
calculated (Fig. S19†), resulting to be particularly high in
hypoxic ASCs and MCF7 cells labeled with metro-NPs (≈128
and 224 respectively), therefore confirming qualitative imaging
results and demonstrating intense potential of negative con-
trast generation.
4. Discussion
Cancer remains one of the most challenging research domains
in medicine.39 In this context, innovative theranostic
approaches aim to optimize the biological properties of nano-
carriers for early-stage tumor detection and targeted therapy.
The malignant progression of solid tumors is associated with
increased metabolism and reduced vascular supply, resulting
in central areas of prominent hypoxia. The adaptive tissue
response to the decreased oxygen tension gives rise to biologi-
cal alterations becoming molecular targets for therapy and
diagnostics.40
Well-known cytotoxins and radiosensitizers for hypoxic
cells, the nitroimidazoles (specifically 2- and 5-nitro deriva-
tives), have been investigated in many clinical studies.34 In
these compounds, the cytotoxicity under hypoxic conditions
has been attributed to the reduction of the nitro group, conse-
quently generating reactive alkylating species, forming
hydroxyl compounds under deoxygenated conditions, increas-
ing the oxidative damage of DNA, and suppressing intracellu-
lar radioprotectors of sulfhydryl compounds.41 IONPs have
also been included in various complex systems for specific
recognition of hypoxic tissues.39,40,42 Interestingly, Mistry et al.
Fig. 7 MRI of hypoxic labeled cells. Representative scheme of the phantom for in vitro cellular MRI (A) composed of a support in agarose-based gel
and glass capillaries containing cell pellets. Multislice imaging of cell pellets was performed on the axial plane. Representative T2 w-MRI of the
pellets of ASCs or MCF7 cells (B and C) 3 days after incubation with PBS (1,4), NPs (2,5), and metro-NPs (3,6), and cultured under normoxic (1,2,3)
and hypoxic conditions (4,5,6, orange circles). The percentage R1 and R2 variation (R1/R2 V) values of labeled pellets with respect to unlabeled cells
were calculated from standard saturation recovery and MSME acquisition protocols (D and E).
Paper Nanoscale































































































proposed a combinatory use of IONPs and nitrite, where the
selective reconversion of nitrite to nitric oxide (NO) in hypoxia
and low pH induced IONPs extravasation with important
implications for the enhancement of conventional and nano-
therapeutic drug delivery.43 However, even though they have
been loaded onto nano-sized systems as hypoxic tumor cyto-
toxins44 or as inducers of hypoxia-responsive drug releasers,45
small molecular bioreductive compounds have never been
used to functionalize nano-vehicles and direct their inter-
actions with cells. In the present study, we developed a novel
metro-conjugated dendron to functionalize IONPs decorated
with coating layers composed of biphosphonated dendrons
and we preliminarily assessed their potential use in bio-
medical applications.
In the absence of appropriate outer layers, bare magnetite
particles might trigger relevant cytotoxic consequences when
the cells experience concentrations above 100 μg mL−1 (ref. 46)
and the negative eﬀects are dose-dependent.47 The need to
extend the NP hydrophilicity, optional conjugation, and the
biocompatibility fueled the engineering of a great diversity of
surface coatings. The size, composition, surface charge, and
structure of coatings influence IONP cytotoxicity.48 Since the
concentration threshold of the non-toxicity range is strictly
dependent on the shell type,48 our cytotoxicity study covered a
range of NP concentrations between 5 and 150 μg Fe mL−1,
similar to previous reports.15 Although metro-NPs exhibited
mild cytotoxic eﬀects upon long-term exposure and high con-
centrations, their overall impact on cell viability was minimal
under all other conditions. In particular, the trypan blue assay
and the LDH release tests demonstrated no massive loss of
membrane integrity due to the NPs. The lack of eﬀects on the
cell activities (such as proliferation or metabolism) confirmed
the biological inertness of the nanomaterials on the cell lines
of two diﬀerent origins. Interestingly, no relevant diﬀerences
in the internalization rate were noticed between endothelial
cells and macrophages, even though a more eﬃcient uptake
was expected from phagocytic macrophages. By measuring the
cellular iron content over time, fast internalization was
observed, showing their high cell loading eﬃciency, consistent
with other nanoformulations and labeling procedures,37,38
which qualifies our NPs as promising tools for sensitive
imaging and cell tracking.38 Moreover, the uptake process at
least partially relied on the endocytic pathway, in accordance
with the receptor-mediated endocytosis mechanism widely
reported in standard labeling procedures based on the direct
co-incubation of cells and nanomaterials.49–51 The good stabi-
lity shown in buﬀers and biological media suggests our nano-
formulation to be highly suitable for in vitro experiments.
However, the description of nanosystem interaction with
human blood components is also of extreme importance,
since most of the future applications of biomedical NPs are
based on intravenous/oral administration. Our NPs were stable
when exposed to plasma components such as HSA, which,
accounting for half of all serum proteins, is the most abundant
protein in human plasma (600–700 μM),52 and also when
exposed to complete human reconstituted serum, suggesting
good potential for successful intra-systemic injection.
Moreover, the assessment of the haemolytic impact is a
necessary part of early preclinical research, as hemolysis can
lead to jaundice, anemia, and other abnormal conditions.53
Here, the hemolysis assays did not highlight any specific hae-
molytic eﬀect due to the metro-functionalization or the nano-
platform itself. The low impact on RBCs might decrease the
potential elimination by macrophages through phosphatidyl-
serine- and scavenger receptor-mediated phagocytosis,53 and
hence prolong the NP circulating time. The first part of this
work proved that in general terms, despite a slight change in
the external surface charge, the metro-NPs and their untar-
geted counterpart display similar properties and equivalently
behave when interacting with normoxic biological systems,
such as cell cultures, 3D tissue constructs and biomimetic
fluids.
In all cells, the nitroimidazole ligands undergo a variety of
enzymatic one-electron decreases, building up a steady-state
level of 1 e− radical anions. This anion reacts preferentially
with O2, thus returning the tracer to its original form.
However, in the absence of O2, it accepts another e
− to
produce an intermediate that is sequentially reduced to an
eﬃcient nucleophile, the R–NH2, which can be easily alkyl-
ated. Its covalent bonding to macromolecules finally results in
cellular retention of the tracer.22–24 The enzyme xanthine oxi-
dases play a catalytic role in these reactions and may further
reduce cellular components.25 Based on their role as hypoxia-
selective cytotoxins for cancer treatment, nitroheterocyclic
compounds have started to be loaded onto colloidal carrier
systems like solid lipid nanoparticles to enhance tumor drug
uptake,20 and are always more frequently involved in the prepa-
ration of various hypoxia-activated and redox-responsive drug
delivery nanocarriers.54–56 In this study, we postulated that in
a reducing environment the exposure of metronidazole on the
surface could facilitate the interaction and aggregation of NPs
with intracellular components, leading to longer retention
times. Indeed, we observed that metro-NP deposits remained
inside the cells longer in chemically induced-hypoxia or fol-
lowing long-term cell preconditioning to low oxygen tension.
Interestingly, even if based on the endocytosis-mediated
internalization as expected for several conventional formu-
lations of nanomaterials,49–51 the intracellular traﬃcking route
of our NPs apparently did not interfere with their capability to
accumulate in the cells under hypoxic conditions.
Nevertheless, the exact mechanism orchestrating the cell-nano-
particle interplay still needs to be elucidated and will therefore
be the subject of future investigations to scrutinize how the
compartmentalization and the precise intracellular location of
NPs over time aﬀects the metronidazole interaction with the
surrounding molecules. As expected, a more intense MRI
signal was detected in hypoxic cells treated with metro-NPs
with respect to control NPs, unlabeled cells and labeled nor-
moxic cells. In normoxia, the extent of the percentage CV
induced by metro-functionalizing the NPs was extremely
reduced. This behaviour would therefore allow for actual
metro-NP-mediated MRI discrimination of hypoxic tissue
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regions only, as under the other conditions the signal diﬀer-
ences are less pronounced. Finally, even though in vivo experi-
ments reporting on the tracking ability, biodistribution, and
fate of metro-NPs are still needed in order to confirm their
actual applicability as hypoxic probes in complex living
systems, their retention in hypoxic tissues is expected to allow
long term-monitoring with limited iron homeostasis imbal-
ance and toxicity. In fact, in our formulation the organic
coating and the IONP core were connected through covalent
binding, a strong bond able to prevent the coating detachment
from the oxide surface, thus stabilizing the inner core and
avoiding its fast degradation.
In conclusion, we evaluated the eﬀects on the cell function-
ality of dendronized metro-functionalized IONPs in endo-
thelial cells, macrophages, and SVF cells, showing encouraging
results in terms of biocompatibility both in conventional
monolayer cultures and 3D tissue-like constructs. Favorable
properties of bio-interaction were described, such as limited
cytotoxicity and almost negligible impact on the cell metab-
olism and growth rate. Moreover, the colloidal stability in bio-
mimetic media suggests that the in vitro experimentation as
well as injection into the circulatory system of living beings are
realistic possibilities for these nano-objects, thus paving the
way for future studies dedicated to testing the hypoxia-induced
accumulation eﬀect in complex in vivo environments. Based
on these data, we conclude that metro-NPs are good candi-
dates for the further development of agents recognizing
hypoxic tissues with relevant impact related to both tumor
investigation and in vitro tissue engineering.
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